LegalJul 28, 2026, 06:08 AM
Johnson & Johnson to Pay $5.5B to Resolve Ovarian Talc Litigation
AI Summary
Johnson & Johnson announced a comprehensive resolution for the ovarian talc litigation, committing $5.5 billion. The agreement, contingent on 95% claimant participation, includes a first payment of up to $3 billion in 2027, with no further payments before 2028. This resolution follows a favorable MDL court ruling regarding specific causation and aims to conclude the 15-year litigation, which the company states lacked scientific merit.
Key Highlights
- Johnson & Johnson reached an agreement for a comprehensive resolution of ovarian talc litigation.
- The agreement involves a $5.5 billion commitment by the company.
- The first payment of no more than $3 billion is due in 2027, with no additional payments before 2028.
- Resolution is conditioned on the express participation of at least 95% of the remaining 76,000 claims.
- The resolution follows a favorable Multi-District Litigation (MDL) court causation ruling.
- The company has prevailed in the overwhelming majority of ovarian cases tried to date.
- The resolution aims to bring finality to the 15-year litigation.
Price Impact
More from JNJ